GO:0019076 viral release from host cell: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019076 viral release from host cell describes the dissemination of mature viral particles from a host cell, either by cell lysis or by budding from the cell membrane.
• Retroviruses such as HIV-1 use the ESCRT machinery to bud from the plasma membrane, a process dependent on viral Gag proteins and host factors like TSG101 and CHMP4B.
• Adenovirus release involves cell lysis and is influenced by host cell networks and trafficking pathways.
• Human cytomegalovirus (HCMV) release is a complex process with many viral and host dependencies identified by high-resolution CRISPR screens.
• Hepatitis B virus (HBV) release requires intracellular trafficking and the endosomal sorting complex, with distinct pathways for virions and subviral particles.
• Studying viral release is critical for antiviral drug development, vaccine design, and understanding viral pathogenesis.
Description
Viral release from host cell (GO:0019076) is a fundamental biological process that enables the spread of viral infection. It encompasses the mechanisms by which mature viral particles exit an infected cell, either through lysis of the host cell or by budding from the plasma membrane. This process is essential for the viral life cycle and is a key target for antiviral therapies. Understanding the molecular details of viral release is crucial for researchers studying virology, cell biology, and infectious diseases. For example, retroviruses like HIV-1 utilize the host ESCRT (Endosomal Sorting Complex Required for Transport) machinery to facilitate budding, a process that has been extensively studied. Similarly, adenoviruses often lyse the host cell to release progeny virions, and their egress can be influenced by cellular networks. The release of hepatitis B virus involves intricate intracellular trafficking and distinct pathways for different viral particles. Recent advances using CRISPR screening have uncovered numerous host dependencies for human cytomegalovirus (HCMV) release, highlighting the complexity of this process. Thus, GO:0019076 represents a convergence point for viral and host factors, making it a rich area for both basic research and therapeutic intervention.
viral release from host cell At A Glance
| GO ID | GO:0019076 |
|---|---|
| GO term | viral release from host cell |
| Ontology | biological_process |
| Synonym | release of virus from host, viral exit, viral release, viral shedding, virus exit from host cell |
| Major function | Dissemination of mature viral particles from a host cell by lysis or budding |
| Related processes | Viral budding, cell lysis, ESCRT pathway, intracellular trafficking |
| Key host factors | ESCRT components (TSG101, CHMP4B), Rab GTPases, cytoskeletal elements |
| Key viral factors | Gag, Envelope glycoproteins, Matrix proteins |
What Is GO:0019076?
According to the Gene Ontology, GO:0019076 viral release from host cell is defined as the dissemination of mature viral particles from a host cell, e.g. by cell lysis or the budding of virus particles from the cell membrane. This process includes the final steps of the viral life cycle where newly assembled virions exit the host cell to infect new cells. It can occur through various mechanisms, including lytic release, where the host cell is destroyed, or non-lytic release, such as budding, where the cell membrane is used to envelop the virion. The term is synonymous with release of virus from host, viral exit, viral release, viral shedding, and virus exit from host cell.
Why Is viral release from host cell Important in Cell Biology?
Viral release is a critical step in the viral life cycle and a major determinant of viral pathogenesis and transmission. Understanding how viruses exit host cells provides insights into fundamental cell biology, such as membrane remodeling and protein trafficking, and offers targets for antiviral drugs. For instance, the discovery that HIV-1 hijacks the ESCRT machinery for budding has led to the development of inhibitors targeting this interaction. Moreover, the release mechanisms of viruses like HCMV and HBV are complex and involve multiple host dependencies, as revealed by genome-wide screens. Studying viral release also informs vaccine design, as the efficiency of release can impact the production of attenuated or inactivated viruses. Therefore, GO:0019076 is a focal point for both basic virology and translational research.
• Essential for viral spread and pathogenesis.
• Target for antiviral therapies, e.g., HIV-1 budding inhibitors.
• Involves host machinery like ESCRT, providing insights into cell biology.
• Different viruses use diverse release strategies: lysis (adenovirus) vs. budding (retroviruses).
• HCMV release dependencies identified by CRISPR screens offer new drug targets.
• HBV release pathways are distinct for virions and subviral particles, impacting infectivity.
• Viral release can modulate host immune responses, e.g., via extracellular vesicles.
• Coagulation and thrombosis can be influenced by viral release mechanisms.
• Adenovirus flow in host cell networks affects release efficiency.
• Understanding release is key for engineering viral vectors for gene therapy.
What Happens During viral release from host cell?
Assembly and Budding at the Plasma Membrane
In simple terms: New viruses are put together and push out through the cell's outer membrane.
For many enveloped viruses, such as retroviruses, viral components are transported to the plasma membrane where assembly and budding occur. The viral Gag protein orchestrates this process by interacting with the membrane and recruiting the ESCRT machinery, specifically TSG101 and CHMP4B, to facilitate membrane scission and release of the virion. This budding process allows the virus to acquire its envelope from the host cell membrane while avoiding cell lysis.
Lytic Release
In simple terms: The cell bursts open, releasing many viruses at once.
Non-enveloped viruses, such as adenovirus, often release via lysis of the host cell. This involves the disruption of cellular membranes, leading to cell death and the release of accumulated virions. The process can be influenced by viral proteins that induce lysis, as well as host cell factors that regulate cell death pathways. Lytic release is efficient but results in the death of the host cell.
Intracellular Trafficking and Release of HBV
In simple terms: Hepatitis B viruses move through the cell in vesicles and are then secreted.
Hepatitis B virus (HBV) release involves complex intracellular trafficking. HBV virions and subviral particles are assembled in the endoplasmic reticulum and Golgi, then transported through the secretory pathway. The release of virions requires the endosomal sorting complex required for transport (ESCRT) and other host factors, while subviral particles can be secreted via a distinct pathway. This intricate process ensures the efficient spread of HBV.
Host Dependency Factors in HCMV Release
In simple terms: Many host proteins help cytomegalovirus get out of the cell.
Human cytomegalovirus (HCMV) release is a highly complex process that depends on numerous host factors. A recent CRISPR screen identified multiple host genes required for HCMV egress, including those involved in vesicular trafficking, membrane remodeling, and the ESCRT pathway. These findings highlight the extensive interplay between HCMV and host cellular machinery during release.
Extracellular Vesicles and Non-infectious Release
In simple terms: Viruses can also exit inside small bubbles called vesicles, which can affect the immune system.
Some viruses, such as varicella zoster virus (VZV), can be released from cells within extracellular vesicles (EVs) that may contain non-infectious viral particles. These EVs can suppress host antiviral responses, as shown for VZV, where non-infectious EVs modulate the immune system. This mode of release represents an alternative strategy for viral dissemination and immune evasion.
Key Genes Involved in GO:0019076 viral release from host cell
The following genes and proteins are key players in the process of viral release from host cells, as supported by the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSG101 | ESCRT-I component, recruits CHMP4B for membrane scission | Essential for HIV-1 budding; target for antiviral drugs |
| CHMP4B | ESCRT-III component, mediates membrane fission | Required for retrovirus release; studied in budding assays |
| Gag | Viral structural protein, orchestrates assembly and budding | Key driver of retrovirus release; interacts with ESCRT |
| Env | Viral envelope glycoprotein, mediates receptor binding | Influences release efficiency and tropism |
| Rab7 | Late endosomal GTPase, involved in trafficking | Implicated in HBV release and endosomal sorting |
| Rab11 | Recycling endosome GTPase, regulates vesicular transport | May affect HCMV egress |
| VPS4 | AAA-ATPase, disassembles ESCRT-III | Required for multiple enveloped virus budding events |
| ALIX | ESCRT-associated protein, binds Gag | Facilitates retrovirus budding in an ESCRT-dependent manner |
| NEDD4 | E3 ubiquitin ligase, ubiquitinates Gag | Promotes budding of retroviruses |
| CD63 | Tetraspanin, marker of extracellular vesicles | Involved in VZV EV release and immune modulation |
| HSP70 | Chaperone, can be exposed on EVs | Modulates immune response during VZV release |
| Annexin A2 | Membrane repair protein | May influence adenovirus release |
| Cofilin | Actin depolymerizing factor | Facilitates adenovirus egress |
| Myosin | Motor protein, involved in vesicle transport | Aids in adenovirus release |
| Clathrin | Vesicle coat protein | Implicated in HBV trafficking |
| AP-1 | Adaptor protein complex | Mediates sorting of HBV particles |
| ESCRT-0 | Ubiquitin-binding complex | Involved in sorting of viral cargo |
| ESCRT-II | Component of ESCRT machinery | Contributes to membrane budding |
How Is viral release from host cell Regulated?
The process of viral release from host cells is tightly regulated by both viral and host factors. Host regulatory mechanisms include the ESCRT pathway, which is controlled by ATPases such as VPS4 and kinases that phosphorylate ESCRT components. Ubiquitination of viral proteins, such as Gag, by host E3 ligases like NEDD4, regulates budding efficiency. Additionally, intracellular trafficking pathways involving Rab GTPases and cytoskeletal elements are subject to regulation by signaling cascades. For example, the PI3K/Akt pathway can influence membrane trafficking and viral egress. In the case of HBV, the release of virions and subviral particles is differentially regulated, with distinct host factors required for each. Furthermore, host immune responses, such as interferon signaling, can modulate viral release by inducing antiviral effectors. Thus, viral release is a highly regulated process that can be targeted therapeutically.
viral release from host cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSG101 | HIV/AIDS, viral budding | KO cell lines (e.g., HEK293T) to assess HIV-1 release |
| CHMP4B | HIV/AIDS, ESCRT-mediated release | Point mutation knock-in to disrupt ESCRT-III function |
| Gag | HIV/AIDS, viral assembly and release | Overexpression of Gag in producer cells to study budding |
| Rab7 | HBV infection, intracellular trafficking | Knockout in hepatoma cells (e.g., HepG2) to measure HBV release |
| CD63 | VZV infection, extracellular vesicle release | Knockout in melanoma cells to study EV-mediated immune suppression |
Viral Release in HIV/AIDS Pathogenesis
HIV-1 release from host cells is a critical step in viral dissemination and AIDS pathogenesis. The virus utilizes the ESCRT machinery to bud from the plasma membrane of infected CD4+ T cells and macrophages. Efficient release allows the virus to spread to new target cells, leading to progressive immune depletion. Antiretroviral therapies often target late stages of the viral life cycle, including release, to reduce viral load. Understanding the molecular details of HIV-1 budding has been instrumental in developing drugs such as protease inhibitors and maturation inhibitors, which indirectly affect release by preventing virion maturation.
Hepatitis B Virus Release and Liver Disease
Hepatitis B virus (HBV) release is a key determinant of viral spread and liver disease progression. HBV virions and subviral particles are released via distinct intracellular trafficking pathways, with the ESCRT machinery playing a role in virion egress. Chronic HBV infection can lead to cirrhosis and hepatocellular carcinoma. Studying HBV release mechanisms has revealed potential therapeutic targets, such as host factors involved in trafficking, to block viral spread. Additionally, the release of subviral particles, which are non-infectious but immunogenic, is important for vaccine development.
Cytomegalovirus Release and Congenital Disease
Human cytomegalovirus (HCMV) release is essential for viral transmission and pathogenesis, particularly in immunocompromised individuals and congenitally infected infants. A recent CRISPR screen identified numerous host dependencies for HCMV egress, including genes involved in vesicular trafficking and membrane remodeling. These findings provide a roadmap for developing new antiviral strategies against HCMV, which can cause severe disease in neonates and transplant recipients. Understanding HCMV release mechanisms may also inform vaccine design.
Viral Release and Coagulation Disorders
Viral release mechanisms can intersect with the coagulation system, leading to thrombotic complications. For example, viral coagulation, as reviewed by Pryzdial et al., involves the interaction of viral particles with coagulation factors, which can promote thrombosis. The release of viruses from host cells, particularly those that bud from the plasma membrane, can expose phosphatidylserine and other procoagulant molecules, contributing to a hypercoagulable state. This is relevant in infections such as HIV and HCMV, where thrombotic events are observed. Thus, viral release is not only important for spread but also for systemic pathology.
From viral release from host cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate HIV-1 release? | Knockout of gene X in HEK293T cells followed by HIV-1 budding assay |
| Does mutation Y in gene X affect HCMV egress? | Point mutation knock-in of Y in fibroblasts, measure viral titer |
| Can gene X be tagged to track its role in viral release? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of gene X enhance HBV release? | Overexpression of gene X in HepG2 cells, quantify HBV DNA in supernatant |
| Which host genes are essential for HCMV release? | Genome-wide CRISPR knockout library screening in HCMV-infected cells |
| Does gene X interact with viral protein Y during release? | Knock-in of epitope tag at gene X locus, co-immunoprecipitation |
How to Study the viral release from host cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Host genes essential for viral release | Identify novel antiviral targets for HCMV |
| Budding assay | Quantity of released viral particles | Assess HIV-1 release after gene knockout |
| qPCR for viral genome | Viral DNA/RNA copies in supernatant | Measure HBV release in cell culture |
| Immunoprecipitation-mass spectrometry | Protein-protein interactions | Discover ESCRT components binding to Gag |
| Live-cell imaging | Real-time visualization of budding | Track retrovirus release dynamics |
| Electron microscopy | Ultrastructural details of release | Observe budding virions at membrane |
| Flow cytometry | Cell surface expression of viral proteins | Monitor release of non-enveloped viruses |
| RNA-seq | Transcriptional changes during release | Identify host pathways upregulated during HCMV egress |
CRISPR Screens for Host Dependency Factors
Genome-wide CRISPR knockout or activation screens are powerful tools to identify host genes required for viral release. For example, a recent screen for HCMV dependencies revealed numerous host factors involved in egress, including those in vesicular trafficking and ESCRT pathways. These screens typically use pooled lentiviral libraries to perturb gene expression, followed by infection with the virus of interest and selection for cells that survive or show reduced viral release. Next-generation sequencing identifies enriched sgRNAs, pinpointing candidate genes. This approach is unbiased and can uncover novel therapeutic targets.
Budding and Release Assays
To study viral release, researchers often use budding assays where viral particles released into the supernatant are quantified. For retroviruses, this can be done by measuring reverse transcriptase activity or viral RNA copies. For HBV, quantification of HBV DNA in the supernatant is common. These assays can be coupled with knockdown or knockout of candidate host genes to assess their role. Additionally, live-cell imaging can visualize the budding process in real-time using fluorescently labeled viral proteins.
Proteomics and Interactomics
Proteomic approaches such as mass spectrometry can identify host proteins that interact with viral components during release. For example, immunoprecipitation of viral Gag followed by mass spectrometry has revealed interactions with ESCRT proteins. Similarly, proximity labeling techniques like BioID can map the interactome of viral proteins at the plasma membrane. These methods provide a comprehensive view of the host machinery hijacked by viruses for release.
Imaging and Trafficking Studies
Advanced imaging techniques, including confocal and electron microscopy, are used to visualize viral release events. For instance, electron microscopy can capture budding virions at the plasma membrane. Fluorescence microscopy with tagged viral and host proteins can track the movement of viral particles through intracellular compartments, as studied for HBV and adenovirus. These methods help elucidate the spatial and temporal dynamics of release.
How CRISPR Can Be Used to Study GO:0019076 viral release from host cell
Knockout
CRISPR knockout (KO) is used to completely ablate a candidate host gene to determine its necessity for viral release. For example, KO of TSG101 or CHMP4B in HEK293T cells significantly reduces HIV-1 budding, demonstrating their essential roles. Similarly, KO of Rab7 in hepatoma cells impairs HBV release. KO models are invaluable for validating host dependency factors identified in screens and for studying the mechanistic basis of release.
Point Mutation
Point mutation knock-in allows the study of specific amino acid residues critical for protein function during viral release. For instance, mutating the PTAP motif in HIV-1 Gag, which binds TSG101, abolishes ESCRT recruitment and budding. By introducing such mutations into the viral genome or host genes, researchers can dissect the molecular interactions required for release. This approach is particularly useful for understanding post-translational modifications and binding interfaces.
Knock-in
Knock-in of tags or reporters enables visualization and tracking of viral or host proteins during release. For example, knocking in a fluorescent tag at the endogenous locus of a host protein can reveal its localization during viral budding. Similarly, knock-in of epitope tags facilitates immunoprecipitation and proteomic analysis. This strategy preserves endogenous regulation and provides physiological relevance.
Overexpression
Overexpression of viral or host genes can enhance viral release and help study its mechanisms. For instance, overexpression of HIV-1 Gag alone is sufficient to drive budding of virus-like particles. Overexpression of host factors like ALIX or NEDD4 can increase release efficiency, allowing researchers to study rate-limiting steps. This approach is also used to produce high-titer viral stocks for gene therapy applications.
How EDITGENE Supports viral release from host cell Research
Researchers studying viral release from host cell-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated. This requires precise genetic manipulation, which can be achieved through CRISPR-based models. EDITGENE provides a comprehensive suite of services to support such investigations, from knockout cell lines to library screening, enabling rigorous and reproducible research.
Contact EDITGENE today to design your custom CRISPR model for viral release from host cell research.
Frequently Asked Questions About viral release from host cell
What is GO:0019076 viral release from host cell?
GO:0019076 is a Gene Ontology biological process term that describes the dissemination of mature viral particles from a host cell, either by cell lysis or budding from the cell membrane.
What genes are involved in viral release from host cell?
Key genes include TSG101, CHMP4B, VPS4, ALIX, and NEDD4, which are part of the ESCRT machinery and ubiquitination pathways, as well as viral genes like Gag. Other host genes such as Rab7 and CD63 are involved in specific virus release.
How do viruses release from host cells?
Viruses can release by lysis, where the host cell bursts, or by budding, where the virus acquires an envelope from the plasma membrane. Budding often requires the ESCRT machinery.
Why is viral release important for disease?
Viral release is essential for viral spread and pathogenesis. It is a target for antiviral drugs and vaccines. For example, blocking HIV-1 release can reduce viral load.
What is the role of ESCRT in viral release?
The ESCRT (Endosomal Sorting Complex Required for Transport) machinery mediates membrane scission during budding of many enveloped viruses, including HIV-1. Components like TSG101 and CHMP4B are recruited by viral proteins to facilitate release.
How can CRISPR be used to study viral release?
CRISPR knockout screens can identify host genes required for viral release. For instance, a genome-wide screen revealed host dependencies for HCMV egress. Knockout cell lines can validate these findings.
What are the different mechanisms of viral release?
Mechanisms include lytic release (e.g., adenovirus), budding from the plasma membrane (e.g., HIV-1), and release via extracellular vesicles (e.g., VZV).
Which viruses use budding for release?
Enveloped viruses such as retroviruses (HIV-1), influenza virus, and hepatitis B virus use budding. Non-enveloped viruses like adenovirus typically use lysis.
What is the role of host trafficking in viral release?
Host intracellular trafficking pathways, including Rab GTPases and the secretory pathway, are hijacked by viruses to transport viral components to release sites. For example, HBV release requires Rab7 and other trafficking factors.
How does viral release relate to coagulation?
Viral release can expose procoagulant molecules, leading to thrombosis. Viral coagulation is a recognized complication of some infections, as reviewed by Pryzdial et al..
Conclusion
Viral release from host cell (GO:0019076) is a pivotal step in the viral life cycle, encompassing diverse mechanisms such as budding, lysis, and vesicle-mediated egress. It relies on intricate interactions between viral proteins and host machinery, particularly the ESCRT pathway, and is a validated target for antiviral intervention. Continued research using advanced tools like CRISPR screens and imaging will further unravel the complexities of this process and inform therapeutic strategies. EDITGENE is committed to supporting this research with high-quality CRISPR models and screening services.
References
- 1. Morita E et al.. 2004. Retrovirus budding.. Annu Rev Cell Dev Biol 20:395-425 PMID: 15473846
- 2. Meier O et al.. 2004. Adenovirus endocytosis.. J Gene Med 6 Suppl 1:S152-63 PMID: 14978758
- 3. Finkel Y et al.. 2024. A virally encoded high-resolution screen of cytomegalovirus dependencies.. Nature 630(8017):712-719 PMID: 38839957
- 5. Jiang B et al.. 2020. Intracellular Trafficking of HBV Particles.. Cells 9(9) PMID: 32887393
- 6. Niemeyer CS et al.. 2024. Suppression of the host antiviral response by non-infectious varicella zoster virus extracellular vesicles.. J Virol 98(8):e0084824 PMID: 39051773
- 7. George Pryzdial EL et al.. 2024. Viral coagulation: pushing the envelope.. J Thromb Haemost 22(12):3366-3382 PMID: 39260743
- 8. Flatt JW et al.. 2019. Adenovirus flow in host cell networks.. Open Biol 9(2):190012 PMID: 30958097
